Epikeratophakia

From WikiMD's WELLNESSPEDIA

Epikeratophakia is a surgical procedure that involves the reshaping of the cornea to correct refractive errors such as myopia, hyperopia, and astigmatism. This procedure was first introduced in the 1980s and has since been largely replaced by other forms of refractive surgery such as LASIK and PRK.

Procedure[edit]

The procedure of Epikeratophakia involves the removal of the epithelium, the outermost layer of the cornea, and the placement of a donor cornea onto the patient's cornea. The donor cornea is shaped to correct the patient's refractive error and is then sutured onto the patient's cornea. The epithelium is then allowed to grow back over the donor cornea.

Advantages and Disadvantages[edit]

Epikeratophakia has several advantages over other forms of refractive surgery. It is a reversible procedure, meaning that if the patient is not satisfied with the results, the donor cornea can be removed. It also does not involve the cutting of the patient's cornea, which can lead to complications such as corneal ectasia.

However, Epikeratophakia also has several disadvantages. The procedure is more invasive than other forms of refractive surgery and requires a longer recovery time. It also has a higher risk of complications such as infection and rejection of the donor cornea.

Alternatives[edit]

There are several alternatives to Epikeratophakia, including LASIK, PRK, and phakic intraocular lenses. These procedures are generally less invasive and have a shorter recovery time than Epikeratophakia.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.